MARKET DEFINITION

Psoriasis is a skin condition that results in bumpy, red patches of skin that are covered in white scales. Although they can grow anywhere, they most frequently manifest on the scalp, elbows, knees, and lower back. The same family can occasionally have it happen to them. Moreover, early adulthood is typically when psoriasis first manifests. It primarily affects a few distinct areas for the vast majority of people. Psoriasis can cover a significant portion of the body in severe cases. Throughout a person's lifetime, the patches might appear and disappear. However, plaque psoriasis, which appears as dry, raised skin patches (plaques) covered in grey or silver scales, is the most prevalent type of psoriasis. It may, however, appear differently depending on skin tone, ranging from pink on white skin to brown or grey on brown or Black skin. Healthy skin cells are unintentionally attacked by infection-fighting cells, which is thought to be an immune system problem. Plaque psoriasis can also be brought on by stress, alcohol or tobacco use, infections, skin injuries, starting or stopping the medication, and several other factors, including infections and skin injuries.

MARKET DYNAMICS

Growing alcohol and tobacco use, which results in immune system deterioration and psoriasis conditions, is one of the main factors fueling the market's expansion. Psoriasis is also increasing in prevalence and awareness, which is anticipated to fuel growth given the abundance of promising new treatments. The market's potential is, however, constrained by the fact that there is no cure for psoriasis and that treatments only work to alleviate severe psoriasis concerns. Additionally, it is expected that the high cost of using modern medications has put additional strain on the average person who is suffering from this autoimmune skin disorder, which will impede the market growth. Furthermore, it is anticipated that the growing demand for psoriasis treatments that are faster, better, and more effective will lead to prosperous opportunities.

REPORT SCOPE

The report titled “Global Plaque Psoriasis Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Plaque Psoriasis market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Plaque Psoriasis market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Plaque Psoriasis Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Plaque Psoriasis Market is segmented based on Treatment Type, End Use, and region. Based on Treatment Type, the market has been segmented into Topical treatments, Phototherapy, Biologics, and Others, whereas based on End Use, the market comprises Hospital, Specialty Clinics, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Plaque Psoriasis market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Plaque Psoriasis market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Plaque Psoriasis market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Plaque Psoriasis industry in the past three years.

Key players in the Global Plaque Psoriasis Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Pfizer Inc.
• GlaxoSmithKline plc
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Sanofi
• Boehringer Ingelheim International GmbH.
• AstraZeneca
• Johnson & Johnson Private Limited
• Bayer AG
• Merck & Co., Inc.
• Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• Cadila Pharmaceuticals
• Eli Lilly and Company
• LEO Pharma A/S

COVID-19 IMPACT ANALYSIS ON GLOBAL PLAQUE PSORIASIS MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Plaque Psoriasis market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Plaque Psoriasis market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the Plaque Psoriasis market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Instrument
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Treatment Type Trends
3.2.2. End Use Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Plaque Psoriasis Market
3.6. COVID-19 Impact Assessment in Plaque Psoriasis Market
3.6.1. Impact Assessment on Global Plaque Psoriasis Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
4.1. Global Plaque Psoriasis Market Share, By Treatment Type, 2017 - 2028 (USD Million)
4.1.1. Topical treatments
4.1.2. Phototherapy
4.1.3. Biologics
4.1.4. Others

Chapter 5. Global Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
5.1. Global Plaque Psoriasis Market Share, By End Use, 2017 - 2028 (USD Million)
5.1.1. Hospital
5.1.2. Specialty Clinics
5.1.3. Others

Chapter 6. Global Plaque Psoriasis Market Overview, By Geography, 2017 - 2028 (USD Million)
6.1. Global Plaque Psoriasis Market Share, By Geography, 2017 - 2028 (USD Million)
6.1.1. Market End Use and Projections, by Countries, 2017 - 2028 (USD Million)
6.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 7. North America Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
7.1. North America Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
7.1.1. Market End Use and projections, 2017 - 2028 (USD Million)
7.1.2. North America Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.1.3. North America Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
7.2. North America Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
7.2.1. U.S. Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
7.2.1.1. U.S. Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.2.1.2. U.S. Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
7.2.2. Canada Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
7.2.2.1. Canada Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.2.2.2. Canada Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
7.2.3. Mexico Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
7.2.3.1. Mexico Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
7.2.3.2. Mexico Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
 

Chapter 8. Europe Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. Europe Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market End Use and projections, 2017 - 2028 (USD Million)
8.1.2. Europe Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.1.3. Europe Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2. Europe Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. Germany Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. Germany Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.1.2. Germany Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2.2. France Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. France Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.2.2. France Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2.3. UK Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. UK Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.3.2. UK Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2.4. Italy Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.4.1. Italy Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.4.2. Italy Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2.5. Spain Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.5.1. Spain Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.5.2. Spain Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2.6. NORDIC Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.6.1. NORDIC Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.6.2. NORDIC Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2.7. Russia and CIS Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.7.1. Russia and CIS Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.7.2. Russia and CIS Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
8.2.8. Rest of Europe Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
8.2.8.1. Rest of Europe Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
8.2.8.2. Rest of Europe Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)

Chapter 9. Asia Pacific Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Asia Pacific Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market End Use and projections, 2017 - 2028 (USD Million)
9.1.2. Asia Pacific Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.1.3. Asia Pacific Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
9.2. Asia Pacific Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. India Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. India Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.1.2. India Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
9.2.2. China Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. China Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.2.2. China Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
9.2.3. Japan Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Japan Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.3.2. Japan Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
9.2.4. ASEAN Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. ASEAN Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.4.2. ASEAN Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
9.2.5. South Korea Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. South Korea Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.5.2. South Korea Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
9.2.6. Australia Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. Australia Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.6.2. Australia Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
9.2.7. Rest of Asia Pacific Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Rest of Asia Pacific Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
9.2.7.2. Rest of Asia Pacific Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)

Chapter 10. South America Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. South America Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market End Use and projections, 2017 - 2028 (USD Million)
10.1.2. South America Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.1.3. South America Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
10.2. South America Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Brazil Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Brazil Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.2.1.2. Brazil Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
10.2.2. Argentina Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. Argentina Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.2.2.2. Argentina Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
10.2.3. Rest of South America Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Rest of South America Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
10.2.3.2. Rest of South America Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)

Chapter 11. Middle East & Africa Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Middle East & Africa Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market End Use and projections, 2017 - 2028 (USD Million)
11.1.2. Middle East & Africa Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.1.3. Middle East & Africa Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
11.2. Middle East & Africa Plaque Psoriasis Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. GCC Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. GCC Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.2.1.2. GCC Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
11.2.2. South Africa Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. South Africa Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.2.2.2. South Africa Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)
11.2.3. Rest of Middle East & Africa Plaque Psoriasis Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of Middle East & Africa Plaque Psoriasis Market Overview, By Treatment Type, 2017 - 2028 (USD Million)
11.2.3.2. Rest of Middle East & Africa Plaque Psoriasis Market Overview, By End Use, 2017 - 2028 (USD Million)

Chapter 12. Competitive Landscape
12.1. Competitive Environment, 2021
12.2. Strategic Framework
12.2.1. Partnership/Collaborations/Agreement
12.2.2. Expansion
12.2.3. Mergers & Acquisitions
12.2.4. New Product Development

Chapter 13. Key Vendor Analysis
13.1. Pfizer, Inc.
13.1.1. Business Overview
13.1.2. Product Benchmarking
13.1.3. Financial Data
13.1.4. Strategic Overview
13.1.5. Key Developments
13.1.6. SWOT Analysis
13.2. GlaxoSmithKline plc
13.2.1. Business Overview
13.2.2. Product Benchmarking
13.2.3. Financial Data
13.2.4. Strategic Overview
13.2.5. Key Developments
13.2.6. SWOT Analysis
13.3. Novartis AG
13.3.1. Business Overview
13.3.2. Product Benchmarking
13.3.3. Financial Data
13.3.4. Strategic Overview
13.3.5. Key Developments
13.3.6. SWOT Analysis
13.4. Mylan N.V.
13.4.1. Business Overview
13.4.2. Product Benchmarking
13.4.3. Financial Data
13.4.4. Strategic Overview
13.4.5. Key Developments
13.4.6. SWOT Analysis
 
13.5. Teva Pharmaceutical Industries Ltd.
13.5.1. Business Overview
13.5.2. Product Benchmarking
13.5.3. Financial Data
13.5.4. Strategic Overview
13.5.5. Key Developments
13.5.6. SWOT Analysis
13.6. Sanofi
13.6.1. Business Overview
13.6.2. Product Benchmarking
13.6.3. Financial Data
13.6.4. Strategic Overview
13.6.5. Key Developments
13.6.6. SWOT Analysis
13.7. Boehringer Ingelheim International GmbH.
13.7.1. Business Overview
13.7.2. Product Benchmarking
13.7.3. Financial Data
13.7.4. Strategic Overview
13.7.5. Key Developments
13.7.6. SWOT Analysis
13.8. AstraZeneca
13.8.1. Business Overview
13.8.2. Product Benchmarking
13.8.3. Financial Data
13.8.4. Strategic Overview
13.8.5. Key Developments
13.8.6. SWOT Analysis
13.9. Johnson & Johnson Private Limited
13.9.1. Business Overview
13.9.2. Product Benchmarking
13.9.3. Financial Data
13.9.4. Strategic Overview
13.9.5. Key Developments
13.9.6. SWOT Analysis
13.10. Bayer AG
13.10.1. Business Overview
13.10.2. Product Benchmarking
13.10.3. Financial Data
13.10.4. Strategic Overview
13.10.5. Key Developments
13.10.6. SWOT Analysis
13.11. Merck & Co., Inc.
13.11.1. Business Overview
13.11.2. Product Benchmarking
13.11.3. Financial Data
13.11.4. Strategic Overview
13.11.5. Key Developments
13.11.6. SWOT Analysis
13.12. F. Hoffmann-La Roche Ltd.
13.12.1. Business Overview
13.12.2. Product Benchmarking
13.12.3. Financial Data
13.12.4. Strategic Overview
13.12.5. Key Developments
13.12.6. SWOT Analysis
13.13. Bristol-Myers Squibb Company
13.13.1. Business Overview
13.13.2. Product Benchmarking
13.13.3. Financial Data
13.13.4. Strategic Overview
13.13.5. Key Developments
13.13.6. SWOT Analysis
13.14. Cadila Pharmaceuticals
13.14.1. Business Overview
13.14.2. Product Benchmarking
13.14.3. Financial Data
13.14.4. Strategic Overview
13.14.5. Key Developments
13.14.6. SWOT Analysis
13.15. Eli Lilly and Company
13.15.1. Business Overview
13.15.2. Product Benchmarking
13.15.3. Financial Data
13.15.4. Strategic Overview
13.15.5. Key Developments
13.15.6. SWOT Analysis
 
13.16. LEO Pharma A/S
13.16.1. Business Overview
13.16.2. Product Benchmarking
13.16.3. Financial Data
13.16.4. Strategic Overview
13.16.5. Key Developments
13.16.6. SWOT Analysis

Chapter 14. Future Outlook of the Market